Mediderma

What Mediderma does

Mediderma is the professional products and treatments division of the Sesderma Group, a Spanish dermatological company founded in 1989 and headquartered in Púbol/Valencia, Spain. The company manufactures and distributes dermo-cosmetic, aesthetic medicine, and dermatology products to healthcare professionals — including dermatologists, aesthetic medicine practitioners, and clinics — through a B2B e-commerce model that requires professional registration and ships internationally across 12+ countries (Spain, Colombia, Poland, Slovakia, Czech Republic, UK, Mexico, Dominican Republic, Peru, USA, Costa Rica, Panama, Russia, and Romania). The portfolio of 526+ products spans chemical peels (FERULAC, RETISES, AZELAC, LACTIPEEL, intimate peel lines), professional microneedling devices (NANOPORE PEN 02, NANOPORE STYLUS), exosome-based sterile solutions (EXOSES LB+, LW, LA, GF Capilar), nano-liposomal mesotherapy solutions, professional masks, and home-care brands (HYLANSES MD, C-DEFENSE MD, SENS-AGE MD, FILLDERMA, C-VIT, HIDRADERM, SESDERMA MEN).

The company's technology platform is built around nanotechnology-based R&D&I: active ingredients are encapsulated in nanosomes/liposomes (phospholipid bilayer vesicles) to enable deeper skin penetration, and exosome technology is positioned as intercellular transmitters that modulate proliferation, differentiation, and migration of neighboring cells. Products are clinically positioned for specific concerns including anti-aging regeneration, hyperpigmentation, scarring, acne, hair loss, and inflammatory skin conditions, supported by training infrastructure (videos, symposiums, congresses, Sesderma TV) and active participation in international dermatology congresses.

Commercially, Mediderma operates a sales-led, professional-channel GTM: it converts healthcare professionals via registration-gated direct e-commerce, device-plus-consumable bundling (NANOPORE devices paired with MESO CIT lubricants and NANO MESO SOLUTIONS), and education-led demand generation. Pricing is not publicly disclosed; free shipping is available from €150 with 48–72-hour delivery. The company has 51–100 employees, no disclosed external funding, and is privately held as part of the Sesderma Group. Revenue, profitability, and headcount trend are not disclosed.

Name

Mediderma

Legal name

Mediderma Shop

Website

https://mediderma.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

51–100 employees

Short description

Mediderma is the Spanish professional-products division of the Sesderma Group, selling nanotechnology-based dermo-cosmetics, exosome solutions, chemical peels, and NANOPORE microneedling devices to registered dermatologists and aesthetic medicine practitioners across 12+ countries via B2B e-commerce.

Ownership category

akta.pro rank

Product category

Professional Dermo-Cosmetics & Aesthetic Medicine

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Medical Equipment and Supplies Manufacturing (3391)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Dermatology Specialty Pharmaceuticals (HLAIACAL)

Keywords

• Professional dermocosmetics
• Aesthetic medicine products
• Chemical peels skincare
• Microneedling devices
• Nanotechnology skincare

Headquarters

HQ city

Púbol

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Professional Skincare Products Sales: Mediderma generates revenue through the sale of professional dermo-cosmetics and aesthetic medicine products directly to registered healthcare professionals and clinics. Products include chemical peels, microneedling devices, exosome solutions, and home care products. The company operates a B2B e-commerce model with international shipping capabilities.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Mediderma manufactures and sells professional-grade dermatological and aesthetic medicine products, including chemical peels, microneedling devices (NANOPORE PEN 02, NANOPORE STYLUS), exosome-based sterile solutions (EXOSES), liposomal nano meso solutions, and complementary professional consumables. Products are sold to registered healthcare professionals (dermatologists, doctors, aesthetic medicine practitioners) through a B2B e-commerce platform with international shipping capabilities.

Product overview

Mediderma is the professional products and treatments division of the Sesderma Group, specializing in dermocosmetics, aesthetic medicine, and dermatology. The company focuses on research, development, and manufacture of medical-use products, specializing in R&D&I and nanotechnology. The product portfolio is organized into professional-use and home-use categories. Professional products include the MICROPUNCTION line featuring NANOPORE PEN 02 and NANOPORE STYLUS wireless microneedling devices, EXOSES (EXOSES LB+, LW, LA, GF) exosome-based solutions, MESO CIT needle lubricants, NANO MESO SOLUTIONS, and NANOMASK face masks. PEELINGS encompass chemical peels including FERULAC, RETISES, AZELAC, LACTYPEEL, and intimate peel treatments (LACTYFERRIN INTIMATE PEEL). APPARATOLOGY includes diagnostic and treatment devices. Home products are organized under HOME PRODUCTS including GLOBAL FILLER, MEDI+DERMA sub-brands (HYLANSES MD, C-DEFENSE MD, SENS-AGE MD, MELA 360, REDNESS CONTROL, SUNYSES MD), and SESDERMA PRODUCTS for skincare, anti-aging, and specialized treatments. The company also provides professional TRAINING through videos, symposiums, and congresses. Mediderma operates internationally across Spain, Colombia, Poland, UK, Mexico, USA, Peru, Dominican Republic, and other markets.

Differentiator

Problem solved

Functional benefit

Brands

• EXOSES: Exosome-based products for skin regeneration, anti-aging, hair care, and treatment of conditions like hyperpigmentation, scars, and inflammatory diseases.
• NANOPORE
• MESO CIT
• NANO MESO SOLUTIONS
• MEDI+DERMA
• SESDERMA PRODUCTS
• GLOBAL FILLER
• AZELAC SYSTEM

Products and services

• NANOPORE PEN 02 A wireless professional microneedling system with an 8V motor reaching up to 9,600 rpm, 6 programmable speeds, and adjustable needle depth from 0.25mm to 1.5mm. Includes two interchangeable batteries with 2 hours of autonomy each. Designed for dermatologists and aesthetic medicine professionals performing collagen-stimulating treatments.
• NANOPORE STYLUS An electric micropuncture medical device indicated to reduce skin imperfections and enhance the effect of active ingredients. Used by dermatologists and aesthetic professionals for transdermal delivery treatments.
• EXOSES Line A product line of exosome-based sterile solutions that act as intercellular transmitters of information for rejuvenation, hyperpigmentation, scars, hair care, and inflammatory diseases. Includes EXOSES LB+ (anti-aging), EXOSES LW (depigmenting), EXOSES LA (anti-aging), and EXOSES GF Capilar (hair care). For healthcare professionals performing advanced dermatological treatments.
• MESO CIT Needle lubricant solutions for transdermic and microneedling treatments. Includes formulations targeting wrinkles, flaccidity, hyperpigmentation, acne scars, and hair care with various growth factors. Used by professionals in combination with NANOPORE devices.
• NANO MESO SOLUTIONS Liposomal sterile solutions for skin aging, acne-prone skin, hyperpigmentation, flaccidity, and hair loss treatments, applied with microneedling devices. Targeted at dermatologists and aesthetic medicine practitioners.
• PEELINGS (Chemical Peels) A range of chemical peel solutions for professional use covering flaccidity, anti-aging, antioxidants, depigmentation, hydration, revitalization, seboregulation, mechanical peels, and intimate treatments. Used by dermatologists and aesthetic professionals.
• APPARATOLOGY (Diagnostic and Treatment Devices) Professional aparatology equipment including WOOD LIGHT for dermatological diagnosis and NANOPORE EMSES RF devices for clinical use by dermatologists.
• COMPLEMENTARY PRODUCTS (Professional) Professional complementary products including masks, cleaning products, professional post-treatment products, sealing gels, and conductive gels used in dermatological and aesthetic procedures.
• HOME PRODUCTS (Dermo-Cosmetic Skincare) Home-use dermocosmetic products sold through professional channels for patient recommendations, including GLOBAL FILLER (FILLDERMA line for post-procedure care), MEDI+DERMA sub-brands (HYLANSES MD, C-DEFENSE MD, SENS-AGE MD, MELA 360), and SESDERMA PRODUCTS (C-VIT, HIDRADERM, SENSYSES, RETISES, DAESES, SESDERMA MEN). Designed for end consumers recommended by professionals.

Quantifiable outcome

• Subjective evaluation of EXOSES LB effectiveness in 34 volunteers showing anti-aging benefits (Data on file, 2024)

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Sesderma GroupcoreOthersMediderma is the professional products and treatments division of the Sesderma Group. The group was founded with the vocation of dermatology to solve skin problems through innovation and proximity to patients, providing global skincare solutions.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• Galderma: Global dermatology-focused pharmaceutical and aesthetics company (Cetaphil, Restylane, Sculptra) operating across Rx, OTC, and aesthetics. Comparable as a much larger incumbent covering professional dermatology, aesthetics, and consumer skincare that Mediderma competes against.
• Cynosure: Aesthetic device manufacturer (lasers, RF, microneedling platforms like Potenza) competing with Mediderma's NANOPORE device line in the professional apparatology category. Comparable on professional-channel device sales and consumable economics.
• Allergan Aesthetics (AbbVie): Aesthetic medicine division of AbbVie offering Botox, fillers, and complementary skincare lines (SkinMedica). Comparable as a broad incumbent in the professional aesthetic channel where Mediderma's NANOPORE and EXOSES compete for treatment-room shelf space.

Direct peers

• iS Clinical: Innovative Skincare markets cosmeceutical lines and post-procedure products to physicians, medical spas, and aesthetic clinics. Comparable on professional skincare, post-procedure regimens (FILLDERMA analog), and clinician education focus.
• Sesderma: Parent-group sister brand offering consumer dermocosmetics with overlapping nanotechnology and liposomal platforms. Highly comparable as the consumer-facing counterpart to Mediderma's professional line, with shared R&D and overlapping product families (C-VIT, HIDRADERM, RETISES).
• ZO Skin Health: Founded by Dr. Zein Obagi, ZO markets physician-dispensed skincare and treatment protocols directly to dermatologists and plastic surgeons. Directly comparable business model: protocols, professional-only distribution, and home-care regimens prescribed by clinicians.
• Obagi Medical: Physician-dispensed skincare brand owned by Estée Lauder targeting dermatology and plastic surgery channels. Directly comparable on prescription-strength skincare, professional-only distribution, and home-care regimen strategy.
• SkinCeuticals: L'Oréal-owned professional skincare brand sold through dermatologists and aesthetic clinics with science-led positioning around vitamin C and corrective actives. Closely comparable to Mediderma's professional-to-consumer model and channel architecture.
• PCA Skin: Professional chemical peel and skincare brand sold through licensed aestheticians, dermatologists, and plastic surgeons. Highly comparable to Mediderma on chemical peel portfolio (AZELAC, LACTYPEEL analog) and professional channel.
• Dermalogica: Professional skincare brand sold through skin therapists, spas, and licensed professionals with strong training infrastructure (International Dermal Institute). Comparable on professional-only distribution, education-led marketing, and treatment-to-home regimen strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/medidermapro
• YouTubeyoutube.com/channel/UCUbjfxUhEZJXwxkAgKO18ZQ
• Facebookfacebook.com/MedidermaPro
• LinkedInlinkedin.com/company/medidermapro
• Instagraminstagram.com/medidermapro

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mediderma